Cell therapy
Originaltitel der Bekanntmachung
Spain – Pharmaceutical products – Suministro de medicamentos destinados a diversas terapias avanzadas para el Servicio Canario de la Salud
Opportunity Score
Warum diese Bewertung?
Chance
65 / 100
Komplexität
40 / 100
Risikofaktoren
Structured data indicates EU-funded, but XML notice states no EU funds. This could affect eligibility or reporting requ...
Full procurement documents (PCAP, etc.) were not analyzed. Critical details on terms, conditions, and requirements may...
Restricted procedure — pre-qualification required
Tiefe Portfolioanalyse
Verwendet:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Überblick
Strong opportunityWichtige Fakten
- EUR 40M estimated value
- Dynamic Purchasing System (DPS)
- Supplies contract
- 1 lot
- Supply of advanced therapy medicinal products (cell therapy) for the Canary Health Service.
- Coverage of various and diverse advanced therapies as technology and research evolve.
Vollständige Zusammenfassung anzeigen
This tender by the Canary Health Service (Dirección General de Recursos Económicos del Servicio Canario de la Salud) is for the supply of advanced therapy medicinal products (cell therapy) via a Dynamic Purchasing System (DPS) under a restricted procedure. The estimated total value is €40,037,508, with a single lot covering various advanced therapies. The deadline for submission is 2030-03-12, providing a long bidding period. Award is based solely on price (100% weight). The tender is conducted in Spanish and appears EU-funded per structured data, though the XML notice indicates no EU funds. Only the TED XML notice was analyzed; full procurement documents are missing.
Risiken
Structured data indicates EU-funded, but XML notice states no EU funds. This could affect eligibility or reporting requ...
Full procurement documents (PCAP, etc.) were not analyzed. Critical details on terms, conditions, and requirements may...
Restricted procedure — pre-qualification required
Analyse kann unvollständig sein
Nur ein Teil der Vergabeunterlagen wurde analysiert. Weitere Anforderungen, Zertifikate oder Einreichungsdokumente können in den übrigen Unterlagen enthalten sein.
Wichtige Anforderungen
Technical
- Supplies of pharmaceutical products classified under CPV 33600000 and 33690000.
- Contract period from 2025-03-12 to 2030-03-12 (5 years).
Administrative
- Electronic submission required.
Zuschlagskriterien
Lot 1
Auftraggeber
Ort
Las Palmas de Gran Canaria, ESP
Auftraggeberprofil
Kennung
21058580149618
Tätigkeit
Health
Lose (1)
LOT-0000
Cell therapy
Supply of various advanced therapy medicinal products (cell therapy) for the Canary Health Service, covering evolving needs as technology and research advance.
EUR 40M
Geschätzter Wert
Ort
Kategorie
Zuschlagskriterien
Frist
Zuschlagsdetails
Precio. . Terapia celular.
Zusätzliche CPV-Codes
Hinweis zum Wert
Originale TED-Daten anzeigen
Originaler Los-Titel
Terapia celular
Originale TED-Beschreibung
Suministro de medicamentos destinados a diversas y variadas terapias avanzadas
Vergabedetails
- Veröffentlichungsdatum
- 12 Mar 2025
- Sprachen
- Spanish
Referenzmetadaten
- Rechtsgrundlage
- 32014L0024
Referenz-IDs
- Ausschreibungs-ID
- 163196-2025
Dokumente (1)
Ähnliche Ausschreibungen
Poland – Various medicinal products – Dostawa produktów leczniczych, nr PN-127/26/TM
Belgium – Various medicinal products – Leveren van paracetamol oplossing voor intraveneus gebruik voor de ziekenhuisapotheek
Belgium – Anaesthetics – LEVEREN VAN ROCURONIUM 50 MG/ 5 ML VOOR INTRAVENEUS GEBRUIK
France – Various medicinal products – FOURNITURE DE MEDICAMENTS RADIOPHARMACEUTIQUES (TEP et SCINTI) ______________________________________________________________________
Belgium – Medicinal products for the respiratory system – LEVEREN VAN PIRFENIDONE 267 mg en 801 mg (filmomhulde) tabletten
Norway – Medical equipments, pharmaceuticals and personal care products – 2801c Medicines infusion injection
Opportunity Score
Warum diese Bewertung?
Chance
65 / 100
Komplexität
40 / 100
Risikofaktoren
Structured data indicates EU-funded, but XML notice states no EU funds. This could affect eligibility or reporting requ...
Full procurement documents (PCAP, etc.) were not analyzed. Critical details on terms, conditions, and requirements may...
Restricted procedure — pre-qualification required
Tiefe Portfolioanalyse
Verwendet:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications